View in EDS HTML Full Text PDF Full Text

Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.

Saved in:
Bibliographic Details
Title: Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors.
Authors: El Zarif T; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Nassar AH; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Pond GR; Department of Oncology, McMaster University, Hamilton, ON, Canada., Zhuang TZ; Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Master V; Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA., Nazha B; Department of Hematology and Medical Oncology, Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA., Niglio S; New York University Grossman School of Medicine, New York, NY, USA., Simon N; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Hahn AW; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pettaway CA; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tu SM; Division of Hematology and Oncology, University of Arkansas for Medical Sciences, Winthrop P. Rockefeller Cancer Institute, Little Rock, AR, USA., Abdel-Wahab N; University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Assiut University Faculty of Medicine, Assiut University Hospitals, Assiut, Egypt., Velev M; Département d'Innovation Thérapeutique et Essais Précoces, Gustave Roussy-Paris-Saclay University, Villejuif, France., Flippot R; Medical Oncology Department, Institute Gustave Roussy, Villejuif, France., Buti S; Department of Medicine and Surgery, Oncology Unit, University Hospital of Parma, Parma, Italy., Maruzzo M; Oncology 1 Unit, Istituto Oncologico Veneto IOV-Istituto Di Ricovero e Cura a Carattere Scientifico, Padova, Italy., Mittra A; Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Gheeya J; Genitourinary Oncology Section, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center-James Cancer Hospital, Columbus, OH, USA., Yang Y; Genitourinary Oncology Section, Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center-James Cancer Hospital, Columbus, OH, USA., Rodriguez PA; Department of Medical Oncology, Hospital Universitario, 12 de Octubre, Madrid, Spain., Castellano D; Department of Medical Oncology, Hospital Universitario, 12 de Octubre, Madrid, Spain., de Velasco G; Department of Medical Oncology, Hospital Universitario, 12 de Octubre, Madrid, Spain., Roviello G; Section of Clinical Pharmacology and Oncology, Department of Health Sciences, University of Florence, Florence, Italy., Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, Florence, Italy.; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy., McKay RR; University of California San Diego, San Diego, CA, USA., Vincenzi B; Medical Oncology Department, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy., Cortellini A; Medical Oncology Department, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom., Hui G; University of California Los Angeles, Los Angeles, CA, USA., Drakaki A; University of California Los Angeles, Los Angeles, CA, USA., Glover M; Division of Medical Oncology, Department of Medicine, Stanford University, Stanford, CA, USA., Khaki AR; Division of Medical Oncology, Department of Medicine, Stanford University, Stanford, CA, USA., El-Am E; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA., Adra N; Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN, USA., Mouhieddine TH; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Patel V; Division of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Piedra A; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Gernone A; Unit of Medical Oncology Policlinico, Bari, Italy., Davis NB; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA., Matthews H; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA., Harrison MR; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, NC, USA., Kanesvaran R; National Cancer Centre Singapore, Singapore., Giudice GC; Department of Medicine and Surgery, Oncology Unit, University Hospital of Parma, Parma, Italy., Barata P; University Hospitals Seidman Cancer Center, Cleveland, OH, USA., Farolfi A; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori,' Meldola, Italy., Lee JL; University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea., Milowsky MI; University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA., Stahlfeld C; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Appleman L; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Kim JW; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA., Freeman D; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA., Spiess PE; Department of Genitourinary Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Necchi A; Department of Genitourinary Oncology, Vita-Salute San Raffaele University, Milan, Italy., Apolo AB; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Sonpavde GP; Division of Medical Oncology, Advent Health Cancer Institute, Orlando, FL, USA.
Source: Journal of the National Cancer Institute [J Natl Cancer Inst] 2023 Dec 06; Vol. 115 (12), pp. 1605-1615.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1460-2105
DOI:10.1093/jnci/djad155